Amplitude Energy (COPJF) Receives a Buy from Canaccord Genuity
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Bullen is a 2-star analyst with an average return of 0.8% and a 44.09% success rate. Bullen covers the Energy sector, focusing on stocks such as Amplitude Energy, Paladin Energy Ltd, and Bannerman Energy.
Amplitude Energy has an analyst consensus of Strong Buy, with a price target consensus of $0.20, a 46.25% upside from current levels. In a report released on July 17, Macquarie also maintained a Buy rating on the stock with a A$0.38 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
WASHINGTON, July 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes' or the 'Company'), today announced the pricing of an underwritten registered direct offering of 7,500,000 shares of its common stock at a price of $8.00 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $60.0 million. The offering is expected to close on or about July 25, 2025, subject to the satisfaction of customary closing conditions. Cantor and Canaccord Genuity acted as joint book-running managers for the offering. Ocean Wall Limited acted as financial advisor. The net proceeds of this offering are expected to be used for general corporate purposes, including working capital, operating expenses, and capital expenditures. The offering is being made pursuant to a shelf registration statement on Form S-3 that was previously filed with and declared effective by the Securities and Exchange Commission ('SEC') and a related registration statement that was filed with the SEC pursuant to Rule 462(b) under the Securities Act of 1933 (and became automatically effective upon filing). This offering is being made only by means of a prospectus supplement and the accompanying prospectus that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's website at When available, copies of the final prospectus supplement and accompanying prospectus relating to these securities may also be obtained by sending a request to: Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022, or by email at prospectus@ or Canaccord Genuity LLC, Attention: Syndication Department, 1 Post Office Square, 30th Floor, Boston, MA 02109, or by email at prospectus@ This press release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ('ASP technology'). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit Forward Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as 'believes,' 'plans,' 'anticipates,' 'expects,' 'estimates,' 'projects,' 'will,' 'may,' 'might,' and words of a similar nature. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including: risks and uncertainties related to the satisfaction of customary closing conditions related to the public offering; the intended use of net proceeds from the public offering; the impact of general economic, industry or political conditions in the United States or internationally; the failure to obtain necessary regulatory approvals and third party consents for the proposed acquisition of Renergen; disruption from the proposed acquisition of Renergen making it more difficult to maintain business and operational relationships; significant transaction costs and unknown liabilities related to the proposed acquisition of Renergen; litigation or regulatory actions related to the proposed acquisition of Renergen; the outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or government regulations or policies in South Africa, the United Kingdom or elsewhere; our reliance on the efforts of third parties; our ability to complete the proposed the construction and commissioning of our enrichment plant(s) or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of any current and future commercial arrangements; our ability to complete certain transactions and realize anticipated benefits from acquisitions and contracts; dependence on our Intellectual Property (IP) rights, certain IP rights of third parties; the competitive nature of our industry; and the factors disclosed in Part I, Item 1A. 'Risk Factors' of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and any amendments thereto and in the company's subsequent reports and filings with the U.S. Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon. Contacts Jason Assad– Investor relationsEmail: Jassad@ 561-709-3043
Associated Press
13 hours ago
- Associated Press
BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025
Rehovot, Israel--(Newsfile Corp. - July 23, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ('BioHarvest' or the 'Company'), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Canaccord Genuity 45 th Annual Growth Conference taking place on August 12-14, 2025 in Boston, Massachusetts. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event and will host a live BioHarvest Sciences corporate presentation as shown below. Canaccord 45th Annual Growth Conference Date: Tuesday, August 12, 2025 Presentation Time: 11:00 a.m. Eastern time Location: InterContinental Boston Hotel | Boston, MA Presentation Link: Sobel said: 'We continue to build strong momentum across both our consumer and CDMO businesses, enabling us to derive the benefits of continued scaling of our business. I look forward to sharing further details of our growth plan at the Canaccord Growth Conference.' Online investors are invited to pre-register for the webcast presentation. For more information on the conference, or to schedule a one-on-one meeting with management, please contact MZ Group at [email protected]. About BioHarvest Sciences Inc. BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit Forward-Looking Statements Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance of additional future contracts. Readers are cautioned that future contracts or increased revenue is not necessarily an increase in net income or profitability as costs will likely increase as well. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. BioHarvest Corporate Contact: Dave Ryan, VP Investor Relations (604) 622-1186 [email protected] Investor Relations Contact: Lucas A. Zimmerman Managing Director MZ Group - MZ North America (949) 259-4987 [email protected] To view the source version of this press release, please visit
Yahoo
16 hours ago
- Yahoo
These 2 Momentum Stocks Are Gaining Steam — Here's Why Big Banks Say They're Headed Higher
Momentum investing is a perennial favorite strategy for stock investors – after all, following the winners always sounds like a good idea. Momentum names are the stocks that started climbing and just kept going. Once that momentum kicks in, these stocks don't stop to wait for anything. Instead, they keep running on a combination of investor confidence and a prevailing trend. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. However, the law of gravity applies in the market just as it does in the physical world – what goes up must eventually come down. The key to success in momentum investing is knowing when to sell and lock in gains, so you're not left standing when the music stops. Finding the best momentum stocks takes more than simply chasing sharp gains. The Wall Street analysts know this, which is why they look beyond the hype and trends to the underlying data – from earnings reports and verified metrics to future projections and forecasts – that support a stock's upward move. We've used the TipRanks database to identify two momentum stocks that are gaining steam – and that analysts say still have more room to run. Both are rated as Buys and are already up more than 40% this year. Let's take a closer look and see what else makes them compelling picks in today's market. APi Group Corporation (APG) The business world is complex. Successful enterprises tend to focus on their core work, making sure to get that right, to make it profitable, to use it to build a loyal customer base. But in all of that, there are the daily tasks of mundane existence – keeping up the building, maintaining the AC, bringing fire safety systems up to code – and these tasks can divert attention from the core business. But those tasks can't be ignored, either, and the first stock we're looking at here, APi Group, has made its own living providing exactly those services. APi is a professional services firm, providing life safety, security, and other specialty services for a varied enterprise customer base that spans a wide range of industries around the world. Drilling down, we find that APi splits its business into two broad segments, Safety Services and Specialty Services. Under the first category, APi supplies a wide range of services related to fire control and protection, including access control, emergency and exit lighting, hazard systems, fire alarm and detection systems, fire pumps, fire sprinkler systems, temperature scanning, and remote monitoring. The company also offers elevator and escalator services through this division, featuring contractual maintenance, modernization, inspections and testing, and on-demand repair. APi Group's Specialty Services are more varied, and include services in building infrastructure, HVAC, and parts fabrication. The company has specific expertise in electric and gas utilities, fiber optics, water and sewer systems, HVAC installations, building information and control systems, and piping and ventilation systems. The company set up its two-sided organization over the last few years, following its 2022 acquisition of the fire and security firm Chubb. That acquisition was valued at approximately $3.1 billion and brought the UK-based Chubb into APi's fold, as one of the many top-tier partners under APi's umbrella. When we turn to APi's financial results, we find that the company last reported results for 1Q25, and beat the forecasts at both the top and bottom lines. The company's revenue, at $1.72 billion for the quarter, was $63.5 million better than expected and was up 7.5% year-over-year. APi's bottom line, reported as a non-GAAP EPS of $0.37, was a penny better than the forecast and was up 8.8% from the prior-year period. We should note here that APG stock is up 45% so far this year. This momentum stock has caught the attention of JPMorgan analyst Tomohiko Sano, who sees potential in the company's addressable market and its fundamentals for expansion. Sano writes, 'APG has transitioned from a post-Chubb integration story to a streamlined operator with two focused platforms: Safety Services and Specialty Services. Firsthand discussions with site leaders and end customers during our visit revealed consistent messaging and operational discipline across the field. The market is fragmented against a TAM of $160B, and we expect multiple expansion with improvements in EBITDA margin driven by rising share and increased service revenue (aiming for 60%). We believe APG's platform strength is now more visible and more scalable than during our prior view… While the stock has performed well year to date, we see further upside as fundamentals strengthen and the visibility into margin expansion and capital deployment improves.' These comments back up the analyst's Overweight (i.e., Buy) rating, while his $42 price target implies a one-year upside potential of 21%. (To watch Sano's track record, click here) There are 9 recent analyst reviews on APG shares, and they are unanimously positive to give the stock its Strong Buy consensus rating. The shares are currently priced at $34.68 and their $38.21 average target price indicates room for a 10% upside on the one-year horizon. (See APG stock forecast) National Fuel Gas Company (NFG) The second stock on our momentum list, National Fuel Gas Company, is a diversified energy firm with operations at all levels of the natural gas industry: upstream, midstream, and downstream. The company operates through four distinct business segments, each with its own focus on the gas sector: exploration & production, pipeline & storage, gathering, and utility. These business segments develop gas resources, move it to the tank farms, and then transfer it to the end-use customers. National Fuel is based in Williamsville, in western New York; its E&P activities are located in the Appalachian region of northwestern Pennsylvania, and its utility customer base, both residential and commercial, is located in adjacent regions of Pennsylvania and New York. Some numbers will show the scale of National Fuel's business. The company's holdings for gas production total approximately 1.2 million net acres and generated 1.2 bcf per day, while its midstream network includes some 2,800 miles' worth of pipelines. On the utility side, National Fuel boasts 755,000 customers. The company has a history of making strong investments to support and enhance the business; since 2010, National Fuel has put $2.9 billion into its midstream services, and over $1 billion into utility safety. Over the past several years, the US natural gas sector has been expanding, as industries seek to shift away from coal and into less expensive and cleaner-burning fuels. Natural gas offers advantages on both fronts, and in the past year National Fuel has been rising as well. The company jumped on that, and in 2020 spent over $500 million to acquire integrated upstream and midstream gathering assets in Pennsylvania from a Royal Dutch Shell subsidiary. More recently, the company's stock price is up, by 52% in the past 12 months and 48% for the year to date. National Fuel now has a market cap of just over $8 billion. Of interest to return-minded investors, National Fuel has a reliable dividend history, and in its last declaration, on June 12, the company instituted a 4% bump in the payment, for its 55th consecutive annual dividend increase. The current payment of 53.5 cents annualizes to $2.14 per common share and gives a forward yield of 2.4%. Looking at the company's earnings, we see that National Fuel brought in $729.95 million in revenue during its fiscal 2Q25. This was up 16% year over year, although it missed the forecast by $44.6 million. The company reported a non-GAAP EPS of $2.39, a figure that was 18 cents per share better than had been anticipated. Bank of America analyst Kalei Akamine likes NFG shares, and he writes of the company's recent past and likely prospects, saying, 'Since acquiring the Eastern Development Area from Shell in 2020, productivity has gotten increasingly better. Our review of recent data shows production tracking 2.6 bcf per thousand feet, 16% ahead of management expectations. We believe this enables a more capital efficient program through the end of the decade. Near term, we see better productivity and strip pricing supporting a strong guide for fiscal 2026, that will be provided with August results.' Looking ahead, Akamine gives some additional reasons to buy into this stock, adding, 'While we note some regulatory risk that may be a headwind to new out of basin egress and operational risk in growing production in the EDA we believe that recent well data, the upstream development outlook, and federal regulatory support for new pipelines have tipped the risk/reward balance creating an attractive entry point.' The BofA analyst goes on to put a Buy rating on NFG shares, which he supports with a $107 price objective, suggesting a 21% upside potential for the stock in the next 12 months. (To watch Akamine's track record, click here) National Fuel's shares have picked up 5 recent analyst reviews, and the 3-to-2 split favoring Buy over Hold gives the stock a Moderate Buy consensus rating. NFG is priced at $88.58, and its $96.25 average target price implies a 9% upside by this time next year. (See NFG stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Sign in to access your portfolio
